Nonpulmonary medical complications in the intermediate and long-term survivor

Clinics in Chest Medicine

Volumn 18, Issue 2, 1997, Pages 367-382

  Maurer, J R ^a   Tewari, S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CISAPRIDE; CORTICOSTEROID; CYCLOSPORIN; DIHYDROFOLATE REDUCTASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METOCLOPRAMIDE; PROTON PUMP INHIBITOR; TACROLIMUS;

AVASCULAR NECROSIS; CHOLECYSTITIS; CHOLELITHIASIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; GASTRITIS; GRAFT REJECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; LUNG TRANSPLANTATION; MYOPATHY; NEPHROTOXICITY; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH PARESIS; SURGICAL TECHNIQUE;

EID: 0030979869     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70385-3     Document Type: Article

References (114)

1. A.H. Abdalla al-Sulaiman M.H. al-Khader A.A. Tacrolimus as an alternative in cyclosporine-induced hemolytic uremic syndrome in a kidney transplant recipient Transplant Int 7 1994 382 384
2. R.W. Allinson S.A. Limstrom G. Sethi Central retinal vein occlusion after heart–lung transplantation Ann Ophthalmol 25 1993 58 63
3. R.M. Aris I.P. Neuringer M.A. Weiner Severe osteoporosis before and after lung transplantation Chest 109 1996 1176 1183
4. J.M. Armitage R.L. Kormos R.S. Stuart Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 1991 877 887
5. J. Aubia J. Masramon S. Serrano Bone histology in renal transplant patients receiving cyclosporine [letter] Lancet 1 1988 1048 1049
6. L.K. Bachrach C.W. Loutit R.B. Moss Osteopenia in adults with cystic fibrosis Am J Med 96 1994 27 34
7. R.A. Baiocchi A. Caligiuri Low-dose IL-2 prevents the development of Epstein-Barr virus-associated lymphoproliferative disorder in the SCID-human mouse [abstract] Blood 82 suppl 1993 385A
8. J.P. Bantle M.S. Paller R.J. Boudreau Long-term effects of cyclosporine on renal function in organ transplant recipients J Lab Clin Med 125 1990 2333 2340
9. M. Barbir M. Rose S. Kushwaha Low-dose simvastatin for the treatment of hypercholesterolemia in recipients of cardiac transplantation Int J Cardiol 33 1991 241 246
10. T.M. Beaver D.A. Fullerton M.R. Zamora Colon perforation after lung transplantation Ann Thorac Surg 62 1996 839 843
11. W.M. Bennett W.C. Buss Cyclosporine and calcium: Implications for drug action, interactions, and toxicity H. Morii Calcium Regulating Hormones, II, Calcium Transport, Bone Metabolism and New Drugs 91 1991 Contrib Nephrol Karger Basel 50 56
12. W.M. Bennett G.A. Porter Cyclosporine-associated hypertension Am J Med 85 1988 131 133
13. N. Berkowitz L.L. Schulman C. McGregor Gastroparesis after lung transplantation Chest 108 1995 1602 1607
14. J.A. Bianco J. Almgren D. Kern Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine Transplantation 51 1991 925 927
15. M. Bilodeau D.H. Fitchett A. Guerraty Dyslipoproteinemias after heart and heart–lung transplantation: Potential relation to accelerated graft arteriosclerosis J Heart Transplant 8 1989 454 459
16. I.T.M. Bloom F.R. Bentley R.N. Garrison Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1 Surgery 114 1993 480 488
17. J. Brunkwall D. Bergqvist S.E. Bergentz Deep venous thrombosis in patients undergoing renal transplantation—effects of cyclosporine A Transplant Proc 19 1987 1814
18. D.E. Butkus G.A. Herrera S.S. Raju Successful renal transplantation after cyclosporine-associated hemolytic-uremic syndrome following bilateral lung transplantation Transplantation 54 1992 159 162
19. R. Cartier F. Dagenais C. Hollmann Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta Ann Thorac Surg 58 1994 789 794
20. D.C. Cattran G. Steiner D.R. Wilson Hyperlipidemia after renal transplantation: Natural history and pathophysiology Ann Intern Med 91 1979 449 554
21. B.B.K. Chan J.A. Kern T.L. Flanagan Effects of in vivo cyclosporine administration on endothelium-dependent response in isolated vascular rings Circulation 86 suppl II 1992 295 299
22. C. Chaparro S. Kesten M. Scavuzzo Osteoporosis in long-term survivors of isolated lung transplantation [abstract] Chest 1994
23. C. Chaparro J.R. Maurer D. Chamberlain Causes of death in lung transplant patients J Heart Lung Transplant 13 1994 758 767
24. A.K. Cheung G.A. DeVault Jr M.C. Gregory A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine J Am Soc Nephrol 3 1993 1884 1891
25. T.M. Coffman D. Carr W.E. Yarger Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity J Clin Invest 43 1987 282 285
26. C.L. Corpier P.H. Jones W.N. Suki Rhabdomyolysis and renal injury with lovastatin use JAMA 260 1988 239 241
27. I. Dawidson P. Rooth D. Fisher Verapamil ameliorates acute cyclosporine A (CsA) nephrotoxicity and improves immunosuppression after cadaver renal transplantation Transplant Proc 21 1989 1511 1513
28. I. Dawidson P. Rooth C. Lu Verapamil improves the outcome after cadaver renal transplantation J Am Soc Nephrol 2 1991 983 990
29. M. Decramer L.M. Lacquet R. Fagard Corticosteroids contribute to muscle weakness in chronic airflow obstruction Am J Respir Crit Care Med 150 1994 11 16
30. P.C. De Groen A.J. Aksamit J. Rakela Central nervous system toxicity after liver transplantation N Engl J Med 317 1987 861 866
31. M. Den Jeijer T. Koster H.J. Blom Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 224 1996 759 762
32. F.E. Dische J. Neuberger J. Keating Kidney pathology in liver allograft recipients after long-term treatment with cyclosporine A Lab Invest 58 1988 395 402
33. S. Durrant P.M. Chipping S. Palmer Cyclosporine A, methylprednisolone, and convulsions [letter] Lancet 2 1982 829
34. C. East P.A. Alivizatos S.M. Grundy Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation N Engl J Med 318 1988 47 48
35. A. El-Gamel N. Noonan B. Keevil Measurement of microalbumin and retinol-binding protein in cardiac and lung transplant recipients Transplant Proc 27 1995 1969 1972
36. A. End A. Stift H. Ring The use of recombinant human erythropoietin in lung transplantation Wien Klin Wochenschr 107/6 1995 181 183
37. A. End A. Stift G. Wieselthaler Anemia and erythropoietin levels in lung transplant recipients Transplantation 60 1995 1245 1251
38. S.B. Fiel Clinical management of pulmonary disease in cystic fibrosis Lancet 341 1993 1070 1074
39. A.E. Frost C.A. Keller The Multi-Organ Transplant Group. Anemia and erythropoietin in recipients of solid organ transplant Transplantation 56 1993 1008 1011
40. C.G. Gallagher Respiratory steroid myopathy Am J Respir Crit Care Med 150 1994 11 16
41. D. Glicklich V.A. Tellis A.J. Matas No association between post-transplant erythrocytosis, thromboembolic events and cyclosporine therapy Transplant Proc 21 1989 2141 2142
42. Goldstein LS, Haug M, Perl J, et al: Central nervous system complications following lung transplantation, in press
43. S.A. Gruber M. Pescovitz R.L. Simmons Thrombo-embolic complications after renal transplantation: Results from the randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin Transplant Proc 19 1987 1815 1816
44. Guilinger RA, Paradis IL, Yousem SA, et al: Pulmonary thromboembolism after human lung transplantation [abstract]. Am J Respir Crit Care Med 151 (suppl):A90
45. D.W. Hanto M. Birkenbach G. Frizzera Confirmation of the heterogeneity of post-transplant Epstein-Barr virus-associated B-cell proliferation by immunoglobulin gene rearrangement analysis Transplantation 47 1989 458 464
46. D.W. Hanto G. Frizzera K.J. Gajl-Peczalsaka Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation Transplantation 39 1985 461 472
47. J.M. Hayes The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation J Urol 149 1993 437 448
48. J.D. Hosenpud R.J. Novick T.J. Breen The registry of the International Society for Heart and Lung Transplantation: Twelfth official report, 1995 J Heart Lung Transplant 14 1995 805 815
49. D.E. Hricik J.T. Mayes J.A. Schulak Independent effects of cyclosporine and prednisone on post-transplant hypercholesterolemia Am J Kidney Dis 18 1991 353 358
50. R.L. Hughes Cyclosporine-related central nervous system toxicity in cardiac transplantation N Engl J Med 323 1990 420 421
51. B.J. Hunt S. Amin O. Halil The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation Transplantation 53 1993 1251 1256
52. B. Huser B. Lammle J. Landmann Von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids Clin Nephrol 34 1990 214 222
53. F. Jahansouz J.M. Kriett C.M. Smith Potentiation of cyclosporine nephrotoxicity by nafcillin in lung transplant recipients Transplantation 56 1993 1045 1048
54. B.A. Julian D.A. Laskow J. Dubovsky Rapid loss of vertebral mineral density after renal transplantation N Engl J Med 325 1991 544 550
55. B.L. Kasiske K.L. Tortorice K.L. Heim-Duthoy The adverse impact of cyclosporine on serum lipids in renal transplant recipients Am J Kidney Dis 6 1991 700 707
56. D.N. Kenagy Y. Schlesinger K. Weck Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease Transplantation 60 1995 547 554
57. Kesten S, Mayne L, Maurer J: Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation in press
58. C. Knoop M. Andrien M. Antoine Severe hemolysis due to donor anti-D antibody after heart–lung transplantation Am Rev Respir Dis 148 1993 504 506
59. D.M. Knowles E. Cesarman Chadburn Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders Blood 85 1995 552 565
60. M. Koegh L. Simons P. Spratt Hyperlipidemia after heart transplantation J Heart Transplant 7 1988 171 175
61. T.J. Kroshus V.R. Kshettry M.I. Hertz Deep venous thrombosis and pulmonary embolism after lung transplantation J Thorac Cardiovasc Surg 110 1995 540 544
62. S.H. Kubo J.R. Peters K.R. Knutson Factors influencing the development of hypercholesterolemia after cardiac transplantation Am J Cardiol 70 1992 520 526
63. A.J. Larner S.C. Sturman J.B. Hawkins Myopathy with ragged red fibres following renal transplantation: Possible role of cyclosporine-induced hypomagnesemia Acta Neurologica 88 1994 189 192
64. G. Laufer V. Grablowitz A. Laczkovics The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low-dose cyclosporine for immunosuppression Am J Thorac Cardiovasc Surg 104 1992 241 247
65. V. Leblond L. Sutton R. Dorent Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed at a single center J Clin Oncol 13 1995 961 968
66. A.H. Lee R. Mull G.F. Keenan Osteoporosis and bone morbidity in cardiac transplant recipients Am J Med 96 1994 35 41
67. M.T. Lozi A. Pestronk W.C. Yee Rapidly evolving myopathy with myosin-deficient muscle fibers Ann Neurol 35 1994 273 279
68. B.P. Lukert L. Raisz Glucocorticoid-induced osteoporosis: Pathogenesis and management Ann Intern Med 112 1990 352 364
69. M.S. Markell N. Sumrani A. DiBenedetto Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients Am J Kidney Dis 22 1993 233 239
70. J.R. Maurer Medical complications following lung transplantation Semin Respir Crit Care Med 17 1996 173 185
71. M.J. Mihatsch G. Thiel B. Ryffel Histopathology of cyclosporine nephrotoxicity Transplant Proc 20 suppl 3 1988 759 771
72. K.T. Montone L.A. Litzky A. Wurster Analysis of Epstein-Barr virus-associated post-transplantation lymphoproliferative disorder after lung transplantation Surgery 119 1996 544 551
73. R.J. Morrison D. Short G.P. Noon Hypertension after lung transplantation J Heart Lung Transplant 12 1993 928 931
74. C. Movsowitz E.M. Fallon F. Ismail Cyclosporine- A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration Endocrinology 123 1988 2571 2577
75. J.A. Murie R.D. Allen C.A. Michie Deep venous thrombosis after renal transplantation Transplant Proc 19 1987 2219 2220
76. B.D. Myers L. Newton C. Boshkos Chronic injury of human renal microvessels with low-dose cyclosporine therapy Transplantation 46 1988 694 703
77. B.D. Myers R. Sibley L. Newton The long-term course of cyclosporine-associated chronic nephropathy Kidney Int 33 1988 590 600
78. G. Navis J. Broekroelofs G.P.M. Mannes Renal hemodynamics after lung transplantation Transplantation 61 1996 1600 1605
79. D.J. Norman D.R. Ilingworth J. Munson Myolysis and acute renal failure in a heart transplant recipient receiving lovastatin N Engl J Med 318 1988 47 48
80. J. Pachon M.I. Lorber M.J. Bia Effects of H2-receptor antagonists on renal function in cyclosporine-treated transplant patients Transplantation 47 1989 254 259
81. G.M. Patrassi M.T. Sartori P. Rigotti Reduced fibrinolytic potential 1 year after kidney transplantation Transplantation 59 1995 1416 1420
82. J.M. Pattison J. Peterson P. Kuo The incidence of renal failure in 100 consecutive heart–lung transplant recipients Am J Kidney Dis 26 1995 643 648
83. I. Penn Incidence and treatment of neoplasia after transplantation J Heart Lung Transplant 12 1993 S328 S336
84. N. Perico J. Dadan G. Remuzzi Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat J Am Soc Nephrol 1 1990 76 79
85. N. Perico C. Zoja A. Benigni Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: Possible relevance to the reduction in glomerular filtration rate J Pharmacol Exp Ther 239 1986 229
86. J.D. Pirsch R.J. Stratta H.W. Sollinger Treatment of severe Epstein-Barr virus induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation Am J Med 86 1989 241 244
87. K.P. Platz A.R. Mueller G. Blumhardt Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and tacrolimus Transplantation 58 1994 170 178
88. M.K. Porayko S.C. Textor R.A.F. Krom Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation Mayo Clin Proc 69 1994 105 111
89. F. Quarto Di Palo A. Elli R. Rivolta Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide Transplant Proc 51 1991 925 927
90. P.S. Randhawa S.A. Yousem I.L. Paradis The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart–lung transplant recipients Am J Clin Pathol 92 1989 177 185
91. R. Rego R. Vargas S. Cathapermal Systemic vascular effects of cyclosporine. A treatment in normotensive rats J Pharmacol Exp Ther 259 1991 905 915
92. P. Rooth I. Dawidson K. Diller Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice Transplantation 45 1988 433 437
93. N.F. Rossi P.C. Churchill F.D. McDonald Mechanism of cyclosporine A-induced renal vasoconstriction in the rat J Pharmacol Exp Ther 250 1989 896 901
94. P.N. Sambrook P.J. Kelly A.M. Keogh Bone loss after heart transplantation: A prospective study 13 1994 116 121
95. U. Scherrer S.F. Vissing B.J. Morgan Cyclosporine-induced sympathetic activation and hypertension after heart transplantation N Engl J Med 323 1990 693
96. M. Schlosberg C. Movsowitz S. Epstein The effect of cyclosporine A administration and its withdrawal on bone mineral metabolism in the rat Endocrinology 124 1989 2179 2184
97. K. Schwechheimer A. Hashemian Neuropathologic findings after organ transplantation. An autopsy study General and Diagnostic Pathology 141 1995 35 39
98. E. Shane M.D.C. Rivas S.J. Silverberg Osteoporosis after cardiac transplantation Am J Med 94 1993 257 264
99. R.S. Shapiro A. Chauvenet W. McGuire Treatment of B-cell lymphoproliferative disorders with interferon-α and intravenous gammaglobulin [letter] N Engl J Med 318 1988 1334
100. P.A. Sheiner E. Mor L. Chodoff Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on tacrolimus Transplantation 57 1994 1132 1133
101. N. Singh T. Gayowski I.R. Marine Hemolytic uremic syndrome in solid-organ transplant recipients Transplant Int 9 1996 68 75
102. P.C. Smith M.S. Slaughter M.G. Petty Abdominal complications after lung transplantation Transplantation 14 1995 44 51
103. P.D. Stein H.A. Saltzman Diagnosis and management of acute pulmonary embolism Clin Chest Med 16 1996 229 233
104. S.H. Subramony D.E. Carpenter S. Raju Myopathy and prolonged neuromuscular blockade after lung transplant Crit Care Med 19 1991 1580 1582
105. E. Taaning N. Morling S.A. Mortensen Hemolytic anemia due to graft-derived anti-B production after lung transplantation Transplant Proc 26 1994 1739
106. A. Termeer A.J. Hoitsma R.A.P. Koene Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients Transplantation 42 1986 220 221
107. Tewari S. St Thomas L. Mehta A.C. The incidence of deep vein thrombosis in lung transplant recipients [abstract] Chest 108 suppl 1995 205
108. C.M. Thaik M.J. Semigran L. Ginns Evaluation of ischemic heart disease in potential lung transplant recipients J Heart Lung Transplant 14 1995 257 266
109. Y. Vanrenterghem L. Roels T. Lerut Thromboembolic complications and haemostatic changes in cyclosporine-treated cadaveric kidney allograft recipients Lancet 1 1985 999 1002
110. R.C. Walker C. Paya W.F. Marshall Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disorder if adult heart, lung, and other solid organ transplantation J Heart Lung Transplant 14 1995 214 221
111. E.E. Weinmann E.W. Salzman Deep-vein thrombosis N Engl J Med 331 1994 1630 1641
112. N. Yoshimura T. Oka M. Okamoto The effects of pravastatin on hyperlipidemia in renal transplant recipients Transplantation 53 1992 94 99
113. S.A. Yousem P. Randhawa J. Locker Post-transplant lymphoproliferative disorders in heart–lung transplant recipients: Primary presentation in the allograft Hum Pathol 20 1989 361 369
114. J.S. Zaltzman Y. Pei J. Maurer Cyclosporine nephrotoxicity in lung transplant recipients Transplantation 54 1992 875 878